Industry: The FDA Can Do More to Speed Development of HDEs

Devices & Diagnostics Letter
Devicemakers are asking for more incentives and flexible standards as the FDA explores ways to encourage the development of devices to treat rare diseases.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $10.00